D-1171-2022 Class II Terminated
FDA drug recall D-1171-2022 was initiated by Glenmark Pharmaceuticals Inc., USA on Jun 29, 2022 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Jun 23, 2023). Affected quantity: 36 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Jul 6, 2022
- Initiation Date
- Jun 29, 2022
- Termination Date
- Jun 23, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 36 bottles
Product Description
Desmopressin Acetate Tablets, 0.2 mg, 100-count bottles, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Colvale-Bardez, Goa 403513, India, NDC 16714-884-01
Reason for Recall
CGMP Deviations
Distribution Pattern
One sole distributor in TX
Code Information
Lot #: 20020121, Exp 01/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1171-2022
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026